ML II/III | Libretes

5 月 5, 2023

ML II/III

Click here to download.

More From the Archives

AAV2/8-mediated expression of modified sulphamidase, liver targeting for improved secretion and brain delivery in IIIA Huntaway dog.

Read More
Gene Therapy for MPS IVA

Read More
Therapeutic Targeting of Wnt/β-Catenin Signaling to Improve Bone Formation in MPS VII

Read More
Targeting mTORCI and autophagy pathways to rescue the skeletal phenotype in MPS mouse models

Read More
Validation of small molecule therapeutic leads for treatment of MPS I disease

Read More

Accessibility Adjustments

Powered by OneTap

Select your accessibility profile

Vision Impaired Mode

Enhances website's visuals

Seizure Safe Profile

Clear flashes & reduces color

ADHD Friendly Mode

Focused browsing, distraction-free

Blindness Mode

Reduces distractions, improves focus

Epilepsy Safe Mode

Dims colors and stops blinking

Content

Colors

Orientation